{"id":529,"slug":"bala-financial-summary","type":"ai_analysis","type_label":"AI Analysis","template_label":"Financial Summary","title":"BALANGODA  PLANTATIONS  PLC Financial Summary","description":"AI-generated company update covering financial performance, balance sheet strength, cash flow, valuation indicators, market context, risks, outlook, and investment decision factors.","chips":["Financial Performance","Ratios","Outlook","Risks"],"source_label":"financial_summary.md","symbol":"BALA.N0000","company_name":"BALANGODA  PLANTATIONS  PLC","sector":"Food, Beverage & Tobacco","status":"published","is_featured":false,"published_at":"2026-08-15T09:33:45Z","updated_at":"2026-08-15T09:33:45Z","source_updated_at":"2026-08-15T09:33:45Z","body_markdown":"# Balangoda Plantations PLC Financial Summary and Investment Analysis\n\n## Executive Overview\n\nBalangoda Plantations PLC is a plantation company engaged principally in **tea, rubber, forestry products and other crops**, operating 21 estates across Balangoda, Badulla and Ratnapura. The Company manages approximately **3,931 hectares of tea and 1,858 hectares of rubber**, with total tea, rubber, timber and other crop fields spanning about 9,076 hectares. Melstacorp PLC is the parent company.\n\n**Periods covered:** Q3 2023 through Q2 2026, audited CY2025 Annual Report, historical annual information through CY2020, and market context through 2026-08-14.\n\nThe central financial trend is a sharp weakening of **core plantation margins** after the strong 2024 period. Audited CY2025 revenue declined 11.6% to Rs.4,279.555 million and gross profit fell 52.6% to Rs.411.506 million. H1 2026 deteriorated further, recording a **gross loss of Rs.12.983 million**, although biological-asset fair-value gains and other income preserved a Rs.130.122 million net profit.\n\nThe balance sheet is considerably stronger than several years ago: equity reached Rs.4,627.987 million by 2026-06-30, there were no term borrowings, and NAV rose to Rs.97.90/share. However, H1 2026 operating cash generation almost disappeared and overdraft usage increased.\n\n## Financial Performance\n\n### Revenue and Profitability Trends\n\n*Rs.'000; quarterly numbers are those reported in each interim. Later audited annual totals supersede unaudited year-end totals.*\n\n| Period  |   Revenue | Gross Profit | Net Profit/(Loss) | GP Margin | NP Margin |\n| ------- | --------: | -----------: | ----------------: | --------: | --------: |\n| Q3 2023 | 1,017,306 |      131,080 |            42,081 |     12.9% |      4.1% |\n| Q4 2023 |   835,510 |       27,847 |            15,477 |      3.3% |      1.9% |\n| Q1 2024 | 1,116,660 |      166,557 |           167,733 |     14.9% |     15.0% |\n| Q2 2024 | 1,343,982 |      360,347 |           289,108 |     26.8% |     21.5% |\n| Q3 2024 | 1,237,654 |      288,365 |           265,172 |     23.3% |     21.4% |\n| Q4 2024 | 1,175,524 |       30,303 |            50,785 |      2.6% |      4.3% |\n| Q1 2025 |   997,385 |       82,215 |           132,248 |      8.2% |     13.3% |\n| Q2 2025 | 1,221,326 |      152,952 |           240,477 |     12.5% |     19.7% |\n| Q3 2025 | 1,157,941 |      142,617 |           123,784 |     12.3% |     10.7% |\n| Q4 2025 |   902,903 |       47,174 |           124,097 |      5.2% |     13.7% |\n| Q1 2026 |   843,154 |    (117,724) |          (41,165) |    -14.0% |     -4.9% |\n| Q2 2026 | 1,089,427 |      104,742 |           171,288 |      9.6% |     15.7% |\n\nQ2 2026 showed a meaningful sequential recovery from Q1: revenue increased 29.2%, gross profitability returned, and the Rs.41.165 million Q1 loss became a Rs.171.288 million profit. Nevertheless, Q2 revenue remained **10.8% below Q2 2025** and net profit was down 28.8% YoY.\n\nFor H1 2026, revenue fell **12.9% YoY** to Rs.1,932.581 million and PAT declined **65.1%** to Rs.130.122 million. More significantly, H1 gross profit moved from Rs.235.167 million in 2025 to a **Rs.12.983 million gross loss**.\n\nAudited CY2025 results were:\n\n* Revenue: **Rs.4,279.555 million**, -11.6%.\n* Gross profit: **Rs.411.506 million**, -52.6%.\n* Operating profit: **Rs.944.947 million**, -15.1%.\n* PBT: **Rs.858.495 million**, -10.3%.\n* PAT: **Rs.596.685 million**, -19.5%.\n* EPS: **Rs.12.62**, versus Rs.15.68.\n* Net margin: **13.9%**, versus approximately 15.3%.\n\nThe 35% plantation wage increase added approximately **Rs.266 million** of annual labour cost.\n\n### Profit Quality and Segments\n\nProfit increasingly depends on non-core/non-cash valuation income. CY2025 biological-asset fair-value gains were **Rs.518.890 million**, exceeding reported gross profit. Excluding this gain, PBT would have been approximately Rs.339.605 million before other adjustments.\n\nThis became more pronounced in H1 2026: PBT was Rs.201.018 million while biological-asset fair-value gains were **Rs.200.195 million**. Core plantation operations therefore generated very little pre-tax profitability independently of valuation gains and other income.\n\n| Segment | CY2025 Revenue | Gross Profit/(Loss) | Gross Margin | H1 2026 Gross Margin |\n| ------- | -------------: | ------------------: | -----------: | -------------------: |\n| Tea     |      3,834,986 |             482,007 |        12.6% |                 2.8% |\n| Rubber  |        444,569 |            (70,501) |       -15.9% |               -27.2% |\n\nTea remains the earnings engine, but its margin has compressed sharply. Rubber remains structurally loss-making at gross-profit level despite stronger selling prices.\n\n## Balance Sheet Analysis\n\n| Rs.'000             | 2024-12-31 | 2025-12-31 | 2026-06-30 |\n| ------------------- | ---------: | ---------: | ---------: |\n| Total assets        |  8,059,127 |  8,954,100 |  9,166,221 |\n| Current assets      |    764,572 |    777,801 |    827,609 |\n| Current liabilities |    914,686 |    744,084 |    728,779 |\n| Total equity        |  3,717,021 |  4,498,048 |  4,627,987 |\n| Cash                |     43,273 |     17,139 |      3,269 |\n| Bank overdraft      |    302,058 |    103,930 |    174,289 |\n| NAV/share           |      78.63 |      95.15 |      97.90 |\n| Current ratio       |      0.84x |      1.05x |     ~1.14x |\n\nEquity strengthened 21% during CY2025, supported by profitability and revaluations. CY2025 included a Rs.386.678 million building revaluation surplus before related deferred tax.\n\nTerm borrowings were fully repaid, materially reducing financial leverage. However, H1 2026 liquidity quality weakened: cash fell to only Rs.3.269 million while the overdraft increased 67.7% from year-end to Rs.174.289 million.\n\nBiological assets remain exceptionally material: bearer and consumable biological assets totaled about **Rs.5.582 billion**, approximately 61% of assets at 2026-06-30.\n\n## Cash Flow Analysis\n\nCY2025 operating cash flow declined from **Rs.1,110.382 million to Rs.481.752 million**. Capital investment was approximately Rs.154 million, implying free cash generation of roughly **Rs.327 million**.\n\nH1 2026 deteriorated sharply:\n\n| Rs.'000                         |   H1 2025 |   H1 2026 |\n| ------------------------------- | --------: | --------: |\n| Operating cash flow             |   226,467 |     4,434 |\n| Investing cash flow             |   (7,231) |  (50,651) |\n| Financing cash flow             | (169,247) |  (38,012) |\n| Period-end net cash/(overdraft) | (208,795) | (171,020) |\n\nApproximate H1 2026 free cash flow after Rs.71.739 million capital expenditure was **negative Rs.67 million**. Receivables, inventories and lower payables absorbed cash.\n\n## Key Financial Ratios and Growth Indicators\n\n| Indicator                 |   CY2025 |\n| ------------------------- | -------: |\n| Gross margin              |     9.6% |\n| Operating margin          |    22.1% |\n| Net margin                |    13.9% |\n| Approx. ROE               |    14.5% |\n| Reported return on assets |      11% |\n| Current ratio             |    1.05x |\n| Quick ratio               |    0.39x |\n| Interest cover            |   10.69x |\n| Debt/total assets         |    0.02x |\n| Asset turnover            |     0.5x |\n| EPS                       | Rs.12.62 |\n| NAV/share                 | Rs.95.15 |\n| Year-end P/E              |     5.7x |\n\nRevenue increased only about **1.8% CAGR from CY2023 to CY2025**, while earnings were highly volatile. Historical PAT moved from a Rs.1.720 million loss in 2021 to Rs.556.927 million in 2022, Rs.69.069 million in 2023, Rs.741.216 million in 2024 and Rs.596.685 million in 2025.\n\n## Economic and Market Context\n\nSri Lankan tea production was broadly flat at **264 million kg in 2025**, but national average tea prices declined to Rs.1,167.72/kg from Rs.1,225.17/kg. Rubber production declined from 69 million kg to 66 million kg.\n\nCompany performance was pressured by lower crop volumes, adverse weather, labour shortages, the 35% wage increase, higher fertilizer/chemical/fuel costs and geopolitical disruption. Rubber production fell 15%, although its net sale average improved 12% to Rs.878/kg.\n\n## Future Potential and Outlook\n\nManagement's 2026 strategy centres on:\n\n* Expanding digitalisation from five estates across the estate network, including drones for foliar spraying and crop mapping.\n* Conversion of Rye/Wikiliya into a fully organic tea garden.\n* Expansion into cinnamon and other diversified crops.\n* Pineapple projects, which generated **Rs.3.7 million profit in 2025**.\n* Potential conversion of selected Ratnapura/Kiriella land to oil palm if the government planting restriction is removed.\n* Flexible production between crepe rubber and RSS according to market demand.\n* Continued factory and field investment; CY2025 capex included Rs.70 million for factories and Rs.49 million for field development.\n\nProduct quality remains a competitive strength: the Company recorded **100 tea top prices and 50 rubber top prices** during 2025, while Telbedde received major tea-quality awards.\n\n## Risks and Challenges\n\nThe principal investment risks are **weather/climate sensitivity, political and geopolitical risk, labour availability and wage inflation, weak rubber economics, commodity-price volatility, and declining core margins**.\n\nThe audit opinion for CY2025 was unmodified. Key audit matters nevertheless highlight material estimation sensitivity around **Rs.3.886 billion of consumable biological assets**, Rs.1.258 billion retirement-benefit obligations and Rs.576 million investment properties. Biological-asset valuations are particularly important because valuation gains materially affect reported earnings.\n\n## Shareholder and Corporate Information\n\nMelstacorp PLC owned **72.21%** at 2026-06-30. Public holding was **27.79%**, represented by 18,611 shareholders; none of the directors or CEO held shares.\n\nThe parent holding has decreased from 74.61% reported in Q3 2023, increasing the public float.\n\nDividend history was Rs.2.00/share for CY2022, nil for CY2023, Rs.1.00 for CY2024 and **Rs.0.50 for CY2025**. CY2025 payout ratio was only 3.96%.\n\nThe latest supplied market snapshot shows a **Rs.62.00 close on 2026-08-14**, a 90-session range of Rs.59-69 and a 3.33% return over those 90 sessions. Trading liquidity remains modest, with median daily turnover of approximately Rs.223,190. Foreign ownership was approximately 0.91%.\n\n## Investment Decision Indicators\n\n**Strengths**\n\n* Stronger equity and NAV; NAV reached Rs.97.90/share.\n* Very low conventional financial debt and substantially lower finance costs.\n* High-quality tea positioning and demonstrated premium-price capability.\n* Significant biological/land-related asset base.\n* Diversification, digitalisation and productivity initiatives provide longer-term optionality.\n* Q2 2026 recovered strongly from the Q1 operating shock.\n\n**Weaknesses**\n\n* H1 2026 core gross margin turned negative.\n* Tea margins have compressed sharply and rubber remains gross-loss-making.\n* Reported profits depend materially on biological-asset fair-value gains.\n* Operating cash flow collapsed to Rs.4.434 million in H1 2026.\n* Cash balance is minimal and overdraft usage is increasing.\n\n**Opportunities**\n\n* Recovery of tea pricing and crop volumes could produce significant operating leverage.\n* Wage-cost productivity initiatives, drones and automation could restore margins.\n* Cinnamon, organic tea, pineapple and possible oil-palm diversification can reduce dependence on traditional crops.\n\n**Threats**\n\n* Wage inflation, labour scarcity, adverse weather and disease.\n* Commodity-price and currency volatility.\n* Geopolitical disruptions affecting export demand and imported inputs.\n* Further deterioration in cash conversion despite accounting profitability.\n\n**Overall assessment:** Balangoda Plantations PLC presently combines **strong asset backing, low term debt and valuable tea franchises with rapidly weakening underlying plantation profitability and cash generation**. The most important indicators to monitor are tea gross margins, rubber losses, operating cash flow, overdraft usage and the proportion of earnings generated from biological-asset revaluations. A sustained restoration of positive core gross margins and cash flow would materially strengthen the financial case; continued dependence on valuation gains while cash generation weakens would materially increase risk.\n"}